INS and metabolic dysfunction-associated steatotic liver disease: A randomized controlled trial demonstrated that the DASH diet exerted beneficial effects on liver enzymes, TGs, inflammatory markers, and insulin metabolism in NAFLD individuals, with recent reports further endorsing its potential as a management strategy for these patients (70).